Health1 month ago
Merck KGaA Secures EU Approval for New Genetic Disorder Treatment
Merck KGaA has received approval from the European Commission for its innovative therapy, Ezmekly, aimed at treating symptomatic, inoperable plexiform neurofibromas in patients diagnosed with neurofibromatosis...